Trial intelligence / Profile preview

KINETAM tamoxifen pharmacokinetics dose-increase study

NL-OMON34869Active, not recruiting

Sponsor
Radboud University Medical Center
Start
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of tamoxifen in breast cancer (2 arms), sponsored by Radboud University Medical Center. Started Jul 2010; status: active, not recruiting.

02

Drugs

tamoxifen
03

Conditions

breast cancer

Beyond the preview

Go deeper on NL-OMON34869.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34869.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call